摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5,6,7,8-Tetrahydro-5-oxo-2-(2-phenylethynyl)-3-quinolinecarbonitrile | 864224-09-9

中文名称
——
中文别名
——
英文名称
5,6,7,8-Tetrahydro-5-oxo-2-(2-phenylethynyl)-3-quinolinecarbonitrile
英文别名
5-oxo-2-(2-phenylethynyl)-7,8-dihydro-6H-quinoline-3-carbonitrile
5,6,7,8-Tetrahydro-5-oxo-2-(2-phenylethynyl)-3-quinolinecarbonitrile化学式
CAS
864224-09-9
化学式
C18H12N2O
mdl
——
分子量
272.3
InChiKey
YVAVZKADSFCNJR-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.8
  • 重原子数:
    21
  • 可旋转键数:
    2
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.17
  • 拓扑面积:
    53.8
  • 氢给体数:
    0
  • 氢受体数:
    3

文献信息

  • Tetrahydroquinolinones and their use as antagonists of metabotropic glutamate receptors
    申请人:Jirgensons Aigars
    公开号:US20050197361A1
    公开(公告)日:2005-09-08
    The invention relates to tetrahydroquinolinone derivatives as well as their pharmaceutially acceptable salts. The invention further relates to a process for the preparation of such compounds. The compounds of the invention are group I mGluR antagonists and are therefore useful for the control and prevention of acute and/or chronic neurological disorders.
    该发明涉及四氢喹诺酮衍生物及其药用可接受的盐。该发明还涉及一种制备这种化合物的方法。该发明的化合物是I组mGluR拮抗剂,因此对于控制和预防急性和/或慢性神经系统疾病非常有用。
  • TETRAHYDROQUINOLINONES AND THEIR USE AS ANTAGONISTS OF METABOTROPIC GLUTAMATE RECEPTORS
    申请人:Merz Pharma GmbH & Co. KGaA
    公开号:EP1723116A2
    公开(公告)日:2006-11-22
  • US7598384B2
    申请人:——
    公开号:US7598384B2
    公开(公告)日:2009-10-06
  • [EN] TETRAHYDROQUINOLINONES AND THEIR USE AS ANTAGONISTS OF METABOTROPIC GLUTAMATE RECEPTORS<br/>[FR] TETRAHYDROQUINOLINONES ET LEUR UTILISATION COMME ANTAGONISTES DES RECEPTEURS DE GLUTAMATE METABOTROPIQUE
    申请人:MERZ PHARMA GMBH & CO KGAA
    公开号:WO2005082856A2
    公开(公告)日:2005-09-09
    The invention relates to tetrahydroquinolinone derivatives as well as their pharmaceutically acceptable salts. The invention further relates to a process for the preparation of such compounds. The compounds of the invention are group I mGluR antagonists and are therefore useful for the control and prevention of acute and/or chronic neurological disorders.
查看更多